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Abstract
Cholesterol is one of the major lipid components of the plasma membrane in mammalian cells and is involved in the
regulation of a number of ion channels. The present study investigates how large conductance Ca2+-activated K+ (BK)
channels are regulated by membrane cholesterol in BK-HEK 293 cells expressing both the a-subunit hKCa1.1 and the
auxiliary b1-subunit or in hKCa1.1-HEK 293 cells expressing only the a-subunit hKCa1.1 using approaches of
electrophysiology, molecular biology, and immunocytochemistry. Membrane cholesterol was depleted in these cells with
methyl-b-cyclodextrin (MbCD), and enriched with cholesterol-saturated MbCD (MbCD-cholesterol) or low-density
lipoprotein (LDL). We found that BK current density was decreased by cholesterol enrichment in BK-HEK 293 cells, with a
reduced expression of KCa1.1 protein, but not the b1-subunit protein. This effect was fully countered by the proteasome
inhibitor lactacystin or the lysosome function inhibitor bafilomycin A1. Interestingly, in hKCa1.1-HEK 293 cells, the current
density was not affected by cholesterol enrichment, but directly decreased by MbCD, suggesting that the down-regulation
of BK channels by cholesterol depends on the auxiliary b1-subunit. The reduced KCa1.1 channel protein expression was also
observed in cultured human coronary artery smooth muscle cells with cholesterol enrichment using MbCD-cholesterol or
LDL. These results demonstrate the novel information that cholesterol down-regulates BK channels by reducing KCa1.1
protein expression via increasing the channel protein degradation, and the effect is dependent on the auxiliary b1-subunit.
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Introduction
Large conductance Ca2+-activated and voltage-dependent K+
(BK, also called Maxi K) channels encoded by KCa1.1 (KCNMA1
or Slo1) gene are widely distributed in smooth muscle, brain,
pancreatic islets, etc., and are essential for the regulation of several
key physiological processes including smooth muscle tone and
neuronal excitability [1,2]. BK channels are formed by a tetramer
of pore-forming a-subunits (KCa1.1 or Slo1) with each a-subunit
containing 7 transmembrane segments (S0–S6) and a large C-
terminal cytoplasmic region [1]. The a-subunit KCa1.1 may
interact with an auxiliary b-subunit [3,4]; four types of b subunits
are identified in different tissues [5,6]. b1 is the predominant BK
channel beta-subunit expressed in smooth muscle cells [7,8] and
regulates the channel sensitivity to Ca2+ ions [6,9]. The expression
of b1 subunit was found to be decreased in vascular smooth muscle
cells in a rat hypertension model [10] and in patients with
hypertension [11].
Activity of BK channels is up-regulated by different signal
pathways including cAMP-dependent protein kinase A (PKA) and
cGMP-dependent kinases [12–14], Src tyrosine kinases [15],
insulin via MAPK activation [16]. In addition, the channel activity
is found to be increased by epoxyeicosatrienoic acid [17] and
arachidonic acid [18]. However, reports on the regulation of BK
current by membrane cholesterol are controversial in different
tissues/cells [19–23].
It has been reported that cholesterol enrichment suppresses BK
channel activity in human melanoma IGR39 cells [20] and in
reconstituted channels in lipid bilayers [21]. However, in rat
uterine myocytes, cholesterol enrichment has no effect on BK
current, while cholesterol depletion suppresses the current [24].
On the other hand, cholesterol depletion up-regulates the BK
activity in colonic epithelial cells and vascular endothelial cells
[25,26]. The present study was designed to determine whether
cholesterol-related alterations of BK channels, which are stably
expressed in HEK 293 cells, are related to the channel protein
level and/or b1 subunit using electrophysiology and molecular
biology approaches. Our results demonstrated that the regulation
of BK channels by cholesterol was dependent on the auxiliary b1
subunit.
Materials and Methods
Cell culture and gene transfection
Human KCa1.1 and KCa1.1-b1 pcDNA3.1 plasmids were
generously provided by Dr. Christopher J. Lingle (Washington
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University, St. Louis, MO). The plasmids (4 mg) were transfected
separately into HEK 293 cells (ATCC, Manassas, VA) in a 35 mm
culture dish with Lipofectamine 2000 to establish stable HEK 293
cell lines. BK-HEK 293 cells stably express both hKCa1.1
(KCNMA1) and b1- (KCNMB1) subunits, and hKCa1.1-HEK 293
cells express only the KCNMA1 gene. The cells were cultured in
Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen, Hong
Kong, China) supplemented with 10% fetal bovine serum (FBS,
Invitrogen) and 400 mg/ml G418 (Invitrogen). Cells used for
electrophysiology were seeded on glass cover slips.
Human coronary artery smooth muscle cells were obtained
from ScienCell Research Laboratory (Carlsbad, CA, USA), and
cultured with a-MEM and F12 medium (Invitrogen) containing
15% FBS.
Chemicals and solutions
Methyl-b-cyclodextrin (MbCD), cholesterol, and low density
lipoprotein (LDL) were purchased from Sigma Chemical (St.
Louis, MO). Lactacystin and bafilomycin A1 were purchased from
Cayman Chemical (Ann Arbor, MI). Stock solutions were made
with ethanol for lactacystin (20 mM) and bafilomycin A1
(10 mM). The stocks were divided into aliquots and stored at
220uC.
Tyrode’s solution contained (mM) NaCl 140, KCl 5.4, MgCl2
1.0, CaCl2 1.8, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES) 10.0 and glucose 10 (pH adjusted to 7.3 with NaOH).
For whole-cell recordings, the pipette solution contained (mM)
KCl 20, K-aspartate 110, MgCl2 1.0, HEPES 10, ethylenegly-
coltetraacetic acid (EGTA) 5, GTP 0.1, Na2-phosphocreatine 5
and Mg-ATP 5 (pH adjusted to 7.2 with KOH). Free Ca2+ of
300 nM in the pipette solution was included as calculated using
the CaBuf software created by Dr. G. Droogmans (Department of
Physiology, KU Leuven, Leuven, Belgium).
Cholesterol enrichment or depletion
The cholesterol enrichment or depletion was conducted in
HEK 293 cell lines with cholesterol-saturated MbCD (MbCD-
cholesterol) or MbCD with the ratio and the procedure as
established previously [27,28]. Briefly, a small volume of
cholesterol stock solution made by dissolving cholesterol in
chloroform: methanol (1:1 vol/vol) was added to a glass tube
and the solvent was evaporated, and then serum-free DMEM
medium containing 5 mM MbCD was added to the dried
cholesterol. The sealed tube was vortexed, sonicated, and
incubated overnight in a shaking bath at 37uC. Cholesterol-
saturated MbCD had a molar ratio of 1:8 (cholesterol: MbCD).
In experiments with cholesterol enrichment or depletion, cells
were washed three times with serum-free DMEM medium, and
then incubated with the medium containing 5 mM MbCD-
cholesterol or 5 mM MbCD for 2 h at 37uC and 5% CO2. After
the treatment, the cells were washed three times with serum-free
DMEM medium and incubated for at least 24 h in serum-free
medium while maintaining the enriched or the depleted choles-
terol. In the study of protein degradation, cells were treated or co-
treated with bafilomycin A1 (1 mM) or lactacystin (20 mM) for 2 h,
and ethanol (equivolume) was used as control. The cells were then
used for electrophysiological recordings and/or molecular biolog-
ical study.
Determination of cellular cholesterol content
Cholesterol content in HEK 293 cells and human coronary
artery smooth muscle cells was determined spectrophotometrically
using a cholesterol/cholesteryl ester quantitation kit (Bio Vision,
Mountain View, CA) following the manufacturer’s instruction.
Briefly, the detached cells were incubated for 10 min at room
temperature in Tyrode’s solution, and then homogenized in
chloroform-Triton X-100. After addition of cholesterol probe, the
cholesterol content was estimated in a colorimetric assay. The
protein content of each sample was determined using a Bradford
protein assay, and the cholesterol concentration was expressed
as mg/mg of protein.
Electrophysiology
BK channel current was recorded using a whole-cell patch
configuration as described previously [29,30]. Briefly, cells on a
coverslip were transferred to a cell chamber (0.5 ml) mounted on
the stage of an inverted microscope (Diaphot, Nikon, Japan) and
superfused at ,2 ml/min with Tyrode’s solution. Borosilicate
glass electrodes (1.2-mm OD) were pulled with a Brown-Flaming
puller (model P-97, Sutter Instrument Co, Novato, CA) and had
tip resistances of 2–3 MV when filled with the pipette solution. A
3-M KCl–agar bridge was used as the reference electrode. The tip
potential was zeroed before patch pipette contact with the cell.
After a giga-Ohm seal was obtained by applying a negative
pressure, the cell membrane was ruptured by applying a gentle
negative pressure to establish whole cell configuration. Series
resistance was 3–6 MV and was compensated by 80% to minimize
voltage errors. The liquid junction potential was not corrected in
the experiment. Membrane currents were measured using an
EPC-10 amplifier and Pulse software (Heka Elektronik GmbH,
Lambrecht, Germany). Command pulses were generated by a 12-
bit digital-to-analog converter controlled by Pulse software.
Current signals were low-pass filtered at 5 kHz and stored in the
hard disk of an IBM compatible computer. All experiments were
conducted at room temperature (22–23uC).
Immunocytochemistry
Immunostaining technique was employed to examine KCa1.1
expression in BK-HEK 293 cells with the procedure as described
previously [30]. Briefly, the cells cultured on coverslips were
washed with PBS, and fixed with PBS containing 2% parafor-
maldehyde (PFA) for 20 min, and subsequently permeabilized
with PBS containing 0.1% Triton X-100 for 3 min. The cells were
washed three times with PBS then incubated with blocking buffer
(5% BSA in PBS) for 1 h. The cells were incubated at 4uC
overnight with the primary antibody (anti-KCa1.1 antibody)
diluted in PBS containing 3% BSA, washed with PBS, then
incubated with the fluorescence-labeled secondary antibody
(Invitrogen) in PBS with 3% BSA in the dark at room temperature
for 1 h. The coverslip was then washed four times with PBS and
mounted with ProLong Gold Anti-fade Reagent (Invitrogen, Hong
Kong, China) for durable visualization. The coverslip was then
observed and captured with confocal microscopy (Olympus
FV300, Tokyo, Japan).
Western blot analysis
The BK channel membrane protein was determined in BK-
HEK 293 cells, hKCa1.1-HEK 293 cells, or human coronary
artery smooth muscle cells with Western blot analysis with the
procedure as described previously [30,31]. Briefly, whole cell
lysates were prepared with a modified RIPA buffer containing
(mM) 50 Tris?HCl, 150 NaCl, 1 EDTA, 1 PMSF, 1 sodium
orthovanadate, 1 NaF, 1 mg/ml aprotinin, 1 mg/ml leupeptin,
1 mg/ml pepstatin, 1% Nonidet P-40, 0.25% sodium deoxycho-
late, and 0.1% SDS. Protein concentration was determined using a
Bio-Rad protein assay, and then used for Western blot analysis.
Cell lysates (40 mg) were mixed with sample buffer and
denatured by heating to 95uC for 5 min. Samples were resolved
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via SDS-PAGE and transferred to nitrocellulose membranes.
Membranes were blocked with 5% nonfat milk in Tris-buffered
saline with Tween (TTBS) and then probed with primary
antibodies at 4uC overnight with agitation. After wash with
TTBS, the membranes were incubated with horseradish perox-
idase-conjugated goat anti-rabbit or donkey anti-goat IgG
antibody at 1:5,000 dilution in TTBS at room temperature for
1 h. Membranes were washed again with TTBS and then
processed onto X-ray film using an enhanced chemiluminescence
detection system (GE Healthcare, Hong Kong, China). The
membranes were then stripped to re-probe with an anti-GAPDH
antibody. The relative intensity of Western blot was measured by a
quantitative scanning densitometer and image analysis software
(Bio-1D version 97.04).
Statistical analysis
The data are expressed as mean6SEM. Nonlinear curve-fitting
was performed using Sigmaplot (SPSS, Chicago, IL). Paired and/
or unpaired Student’s t-test were used as appropriate to evaluate
the statistical significance of differences between two group means,
and two-way ANOVA was used for multiple groups. Values of
P,0.05 were considered to be statistically significant.
Results
BK channel current in HEK 293 cells
BK current showed a strong outward rectification in BK-HEK
293 cells stably expressing hKCa1.1 and the auxiliary b1 subunit.
The current was reversibly inhibited by the BK channel blocker
paxilline (1 mM) as shown in Figure S1 in File S1.
Cholesterol and BK channel current
The effect of MbCD, MbCD-cholesterol complex or LDL on
membrane cholesterol content was determined in BK-HEK 293
cells. MbCD (5 mM) significantly reduced the cellular cholesterol
content from 13.061.9 mg/mg in control to 7.461.0 mg/mg
protein (n = 5, P,0.05 vs. control), whereas 5 mM MbCD-
cholesterol complex increased the cholesterol content to
19.862.3 mg/mg protein (n = 5, P,0.05 vs. control). LDL
increased the cholesterol content to 21.564.2 mg/mg protein
(n = 5, P,0.05 vs. control), while the increase was reduced to
14.461.6 in cells with both LDL and MbCD (n= 5, P,0.05 vs.
LDL alone).
Figure 1 illustrates the effect of cholesterol depletion or
enrichment on BK channel current. Depletion of membrane
cholesterol with 5 mM MbCD slightly increased BK current,
while cholesterol enrichment with MbCD-cholesterol complex
remarkably reduced the current amplitude (Figure 1A). The I-V
relationships (Figure 1B) of BK current showed a reduced current
density at test potentials between210 and +60 mV in cells treated
with cholesterol enrichment (n = 25, P,0.05 or P,0.01 vs.
control) and a slight increase in the current density in cells with
cholesterol depletion. At +60 mV, the current was increased to
105.669.7% of control in cells with cholesterol depletion (n= 23,
P=NS vs. control), and reduced to 60.567.2% of control in cells
with cholesterol enrichment (n = 33, P,0.01 vs. control)
(Figure 1C).
The mean values of the variables of the voltage-dependent
activation calculated from the I-V relationships (Figure 1B) of BK
current for individual cells based on the formulation g = I/(Vt-Vr)
as described previously [32], where I is the current at the test
voltage (Vt), and Vr is the measured reversal potential (270 mV).
The voltage-dependence of the conductance normalized to the
conductance at +60 mV is shown in Figure 1D. The variables
were fitted to a Boltzmann function to obtain the half voltage
(V1/2) of BK channel activation. The V1/2 of BK channel
activation was 5.561.2 mV in control, 1.461.1 mV in MbCD,
8.161.6 mV in MbCD-cholesterol (n = 16 for each group, P=NS
vs. control). No significant difference in slope factor of the curves
was observed with different treatments. These results suggest that
cholesterol enrichment significantly decreases BK current density
without affecting the voltage-dependent activation in BK-HEK
293 cells.
Single channel activity of BK channels in cells with
cholesterol-enrichment
To determine whether the reduced current of BK channels is
related to the alteration in single channel open probability or
unitary conductance, single channel activity of BK channels was
recorded in cell-attached mode with the procedure as described
previously [33] in cells treated with MbCD or MbCD-cholesterol.
Figure 2A illustrates the raw data of single channel activity of BK
channels. Two open levels of single channel were observed in
control cells and in MbCD-treated cells, but not in cells treated
with MbCD-cholesterol. In addition, single channel opening
events were clearly reduced in cells with cholesterol enrichment
(Figure 2A and 2B), suggesting that both current density and open
probability are reduced. The analysis of single channel open
probability revealed that the mean open probability of single BK
channel (Figure 2 C) was significantly lower in cells with
cholesterol enrichment (n = 7, P,0.01 vs. control). However,
unitary conductance of single channels was not affected in cells
with cholesterol depletion or cholesterol enrichment (Figure 2D).
These results suggest that the decreased BK current by cholesterol-
enrichment is likely related to the reduction of channel density and
channel open probability.
Cholesterol enrichment and KCa1.1 protein expression
To examine whether the reduced BK channel current density is
related to the decrease of KCa1.1 protein level, KCa1.1 protein
and b1-subunit protein were determined using Western blot
analysis in cells with different treatments. Figure 3 illustrates the
Western immunoblots and mean percentage values of KCa1.1
protein and b1-subunit protein, and immunocytochemical staining
in cells treated with MbCD or MbCD-cholesterol. The KCa1.1
protein level was reduced by MbCD-cholesterol. Cholesterol
enrichment with MbCD-cholesterol reduced the expression of
KCa1.1 protein to 64.468.1% (Figure 3B) of control (n = 9,
P,0.01 vs. control). However, KCa1.1 b1-subunit protein
(Figure 3B) was not decreased by MbCD-cholesterol (n = 8,
P=NS vs. control). The results (Figure 3C) of the immunocyto-
chemistry also showed a reduced KCa1.1 protein on the cell
membrane in cells with cholesterol-enrichment. These results
indicate that decreased KCa1.1 protein expression is also involved
in the reduced BK current by cholesterol-enrichment.
Effect of low density lipoprotein on BK channels
The effect of the cholesterol donor low density lipoprotein
(LDL) on BK channels was determined in BK-HEK 293 cells
incubated with LDL (75 mg/mL) for 48 h. Figure 4A shows that
BK current was decreased in cells treated with LDL, and the effect
was reduced in cells treated with LDL plus 5 mMMbCD. The I-V
relationships of BK current in Figure 4B show that LDL decreased
the current density at 210 to +60 mV (n= 25, P,0.05 or P,0.01
vs. control). The current at +60 mV was reduced to 63.766.8% of
control (n = 32, P,0.01 vs. control) in cells treated with LDL, and
reversed to 94.266.5% of control (n = 10, P,0.01 vs. LDL alone)
Cholesterol and BK Channels
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in cells treated with both LDL and MbCD (Figure 4C). The
variables of voltage-dependent activation of BK channels calcu-
lated from the I-V relationships (Figure 4B) were fitted to a
Boltzmann function (Figure 4D), and the V1/2 of the channel
activation was 6.661.4 mV in control, 10.261.7 mV in LDL, and
5.861.5 mV in LDL plus MbCD (n= 10 for each group, P=NS
vs. control), suggesting that LDL, like MbCD-cholesterol, reduces
BK current without significantly affecting the voltage-dependent
activation.
The results (Figure 4E and 4F) from Western blot analysis
demonstrated that LDL, similar to MbCD-cholesterol, reduced
KCa1.1 protein (by 44.769.8%, n= 6, P,0.01 vs. control), but
not b1-subunit protein. The reduced KCa1.1 protein was reversed
in cells treated with LDL plus MbCD. These results indicate that
LDL, like MbCD-cholesterol, reduces BK current density and
membrane channel protein.
Figure 1. Effects of cholesterol on BK channel current. A. Voltage-dependent BK current elicited with 300-ms voltage steps between 270 and
+60 mV from a holding potential of -80 mV in BK-HEK 293 cells without treatment (control) or with cholesterol depletion (MbCD) or cholesterol
enrichment (MbCD-cholesterol). The current was recorded with the pipette solution containing 300 nM free Ca2+. B. I-V relationships of BK current in
control (n = 25), with cholesterol depletion or cholesterol enrichment (n = 25, *P,0.05 or **P,0.01 vs. control). C. BK current (as a percentage of
control) at +60 mV in control (n = 25), cholesterol depletion (n = 23, P=NS vs. control), and cholesterol enrichment (n = 33, **P,0.01 vs. control). D.
Activation curves calculated with I-V relationships of the current in panel B and fitted to the Boltzmann function: y = 1/{1+exp[(Vm-V1/2)/S]}, where Vm
is membrane test potential, V1/2 is the midpoint of activation potential, and S is slope.
doi:10.1371/journal.pone.0079952.g001
Cholesterol and BK Channels
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Cholesterol enrichment and KCa1.1 channel protein
degradation
It is generally recognized that protein degradation is mainly
mediated by proteasome pathway and lysosome pathway [34]. To
determine whether the channel degradation process is involved in
the reduction of KCa1.1 protein expression by cholesterol
enrichment, the classical proteasome inhibitor lactacystin [35]
and the lysosomal function inhibitor bafilomycin A1 [36] were
applied in BK-HEK 293 cells. Bafilomycin A1 (1 mM) or
lactacystin (20 mM) had no effect on BK channel current.
Interestingly, both inhibitors reversed the BK current reduction
induced by MbCD-cholesterol (Figure 5A). The mean values of
current density (Figure 5B) at +60 mV were not affected by
bafilomycin A1 (n= 16, P=NS vs. control) or lactacystin (n = 18,
P=NS vs. control), but reduced by MbCD-cholesterol (n = 15,
P,0.01 vs. control), and the reduction by MbCD-cholesterol was
reversed by the addition of bafilomycin A1 (n = 18, P,0.01 vs.
MbCD-cholesterol) or lactacystin (n = 16, P,0.01 vs. MbCD-
cholesterol). Figure 5C and 5D illustrate the Western immunoblots
and mean percentage values of KCa1.1 protein level in cells
treated with bafilomycin A1, lactacystin, MbCD-cholesterol,
MbCD-cholesterol plus bafilomycin A1, or MbCD-cholesterol
plus lactacystin. The KCa1.1 protein was reduced by cholesterol
enrichment with MbCD-cholesterol, and the effect was reversed
Figure 2. Single channel activity of BK channels. A. Single channel activity of BK channels recorded with cell-attached mode at +60 mV in cells
treated with 5 mM MbCD or MbCD-cholesterol. The labels C, O1 and O2 indicate the close level, 1
st and 2nd opening levels of the channel. B.
Histograms of open probability of BK single channels in cells treated without (control) or with cholesterol enrichment (MbCD-cholesterol). C. Mean
values of open probability of BK channels in control (n = 7), MbCD (n= 6), and MbCD-cholesterol (n = 7, **P,0.01 vs. control). D. Conductance of BK
channels in control, MbCD, and MbCD-cholesterol (n = 6–7, P=NS vs. control).
doi:10.1371/journal.pone.0079952.g002
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by the lysosomal inhibition with bafilomycin A1 or the proteasome
inhibition with lactacystin. These results indicate that the
reduction of BK channels by cholesterol enrichment is related to
facilitating channel protein degradation.
b1 subunit-dependent regulation of BK channels by
cholesterol
To determine whether the auxiliary b1 subunit of BK channels
is critical for the cholesterol regulation, further experiments were
performed in hKCa1.1-HEK 293 cells not co-expressing the b1-
subunit. Figure 6A shows that voltage-dependent current traces
recorded in representative cells treated with MbCD or MbCD-
cholesterol. It is interesting to note that the current amplitude of
KCa1.1 channels is reduced in the cells treated with MbCD, and
slightly increased in the cells incubated with MbCD-cholesterol.
Figure 6B shows the I-V relationships of KCa1.1 current with a
relatively positive threshold potential of the channel activation,
which implies the reduced Ca2+-sensitivity. The current density
was reduced at test potentials between +10 and +60 mV in cells
with cholesterol depletion using 5 mM MbCD (n= 19, P,0.05 or
P,0.01 vs. control). The current at +60 mV was reduced to
52.3612.8% of control (n = 19, P,0.01 vs. control). No effect was
observed in cells with cholesterol enrichment (n = 11, P=NS vs.
control) (Figure 6C).
To determine whether MbCD-induced reduction of KCa1.1
current is related to the alteration in single channel open
probability or unitary conductance, single channel activity of
KCa1.1 channels was recorded in hKCa1.1-HEK 293 cells
treated with MbCD or MbCD-cholesterol. Figure 6D illustrates
the single channel activity of KCa1.1 channels. Two open levels of
single channel were observed in control cells, MbCD cells, and in
MbCD-cholesterol cells, suggesting that channel density would not
be altered. However, opening events were reduced in MbCD cells.
The analysis of single channel open probability (Figure 6E)
revealed that the mean open probability of single KCa1.1 channel
(Figure 6F) was significantly decreased in cells treated with MbCD
(n= 5, P,0.05 vs. control). However, unitary conductance of
single channels was not affected in cells with cholesterol depletion
Figure 3. Protein expression of BK channels in BK-HEK 293 cells with co-expressing auxiliary b1-subunit. A. Western immunoblots
showing KCa1.1 protein and the auxiliary b1-subunit protein in cells treated with cholesterol depletion (MbCD) or cholesterol enrichment (MbCD-
cholesterol). B. Mean percentage values of KCa1.1 protein and the b1-subunit protein in cells with different treatments (n = 6–9, **P,0.01 vs. control).
C. Immunocytochemistry showing membrane expression of KCa1.1 protein in cells treated with cholesterol depletion (MbCD) or cholesterol
enrichment (MbCD-cholesterol). Cholesterol enrichment induced a reduction of membrane expression of BK channels.
doi:10.1371/journal.pone.0079952.g003
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or cholesterol enrichment (Figure 6G). These results suggest that
the decreased KCa1.1 current by MbCD is likely related to the
reduction of channel open probability in hKCa1.1-HEK 293 cells.
It is interesting to note that KCa1.1 protein, as shown in Figure
S2 in File S1, was not affected by cholesterol depletion or
cholesterol enrichment in hKCa1.1-HEK 293 cells, which differs
from that in BK-HEK 293 cells expressing both hKCa1.1 and b1-
subunits. The decrease of hKCa1.1 current by cholesterol
depletion with MbCD was not related to reduction of the channel
protein, suggesting that the auxiliary b1-subunit of BK channels
plays a crucial role in the channel regulation by cholesterol, and
MbCD shows a direct inhibition of the channel by reducing the
open probability in hKCa1.1-HEK 293 cells.
Cholesterol enrichment and KCa1.1 expression in human
coronary artery smooth muscle cells
To investigate whether cholesterol enrichment affects native
KCa1.1 expression, the effect of MbCD, MbCD-cholesterol
complex, or LDL on membrane cholesterol content was deter-
mined in cultured human coronary artery smooth muscle cells that
express the auxiliary b1-subunit [37]. MbCD (5 mM) significantly
reduced the cellular cholesterol content from 7.761.1 mg/mg in
control to 3.960.8 mg/mg protein (n = 5, P,0.05 vs. control),
whereas 5 mM MbCD-cholesterol complex increased the choles-
terol content to 12.061.7 mg/mg protein (n = 5, P,0.05 vs.
control. LDL increased the cholesterol content to 12.861.2 mg/
mg protein (n = 5, P,0.01 vs. control), while the increase was
reduced to 5.661.2 mg/mg in cells co-treated with both LDL and
MbCD (n= 5, P,0.05 vs. LDL alone). It should be noted that
cholesterol content is lower in cultured human coronary artery
smooth muscle cells than that in HEK 293 cells (7.7 mg/mg vs.
13 mg/mg), suggesting that the basal content of membrane
cholesterol is cell type-dependent.
BK current was recorded in cultured human coronary artery
smooth muscle cells treated with MbCD, MbCD-cholesterol
complex or LDL. We determined the whole-cell BK current in
cells without/with treatment of MbCD or MbCD-cholesterol
complex (Figure 7A–7C); we were unable to record the current in
cells treated with LDL or LDL plus MbCD due to difficulty in
obtaining a tight-seal in these cells for the whole-cell recording.
BK current was inhibited by paxilline in human coronary artery
smooth muscle cells (Figure 7A). The current was reduced in cells
treated with MbCD-cholesterol complex, but not in cells treated
with MbCD (Figure 7B). BK current at +80 mV (Figure 7C) was
decreased to 56% of control (n = 5, P,0.01 vs. control) in cells
treated with MbCD-cholesterol complex.
The KCa1.1 protein expression level was then determined in
cultured human coronary artery smooth muscle cells with different
treatments. Figure 7D shows the Western blots in cultured human
coronary artery smooth muscle cells. KCa1.1 protein was also
decreased by cholesterol enrichment with MbCD-cholesterol or
LDL in human coronary artery smooth muscle cells. The KCa1.1
protein level (Figure 7E) was decreased to 24.6613.3% of control
in cells treated with MbCD-cholesterol (n = 9, P,0.01 vs. control),
and 44.1610.9% in cells treated with LDL (n = 6, P,0.01 vs.
control). Cholesterol depletion with MbCD slightly increased
Figure 4. Effects of LDL on BK channel current in BK-HEK 293 cells. A. Voltage-dependent BK current recorded with voltage protocol as
shown in the inset in cells treated with LDL (75 mg/mL) or LDL plus MbCD treatment. B. I-V relationships of BK current in control, LDL or LDL plus
MbCD treatment (n = 25, *P,0.05; **P,0.01 vs. control). C. Percentage values compared to control of BK current at +60 mV in control (n = 25), with
LDL (n = 32, **P,0.01 vs. control), and LDL plus MbCD treatment (n = 10, ##P,0.01 vs. LDL alone). D. Activation variables calculated with I-V
relationships of the channel current in panel B were fitted to a Boltzmann function. E. Western immunoblots showing KCa1.1 protein and the
auxiliary b1-subunit protein in cells treated with LDL or LDL plus MbCD. F. Mean percentage values of KCa1.1 protein and the auxiliary b1-subunit
protein in cells with LDL or LDL plus MbCD (n= 6-9, **P,0.01 vs. control, #P,0.05 vs. LDL alone).
doi:10.1371/journal.pone.0079952.g004
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KCa1.1 protein (116.1615.1%, n= 9, P=NS vs. control). LDL-
induced reduction of KCa1.1 protein was significantly reversed by
co-incubation with 5 mM MbCD (78.1619%, n= 6, P,0.05 vs.
LDL alone). These results indicate that KCa1.1 channels in
human coronary artery smooth muscle cells are down-regulated by
cholesterol-enrichment with MbCD-cholesterol or LDL, similar to
KCa1.1 expressed in BK-HEK 293 cells.
Discussion
The present study has demonstrated that the cholesterol
enrichment reduces the current density, single channel open
probability and KCa1.1 protein expression level in BK-HEK 293
cells. The reduction of KCa1.1 protein by cholesterol enrichment
can be reversed by proteasome inhibition with lactacystin or the
lysosome inhibition with bafilomycin A1, suggesting that choles-
terol enrichment-induced BK channel reduction involved protein
degradation. However, cholesterol enrichment did not induce BK
channel suppression in hKCa1.1-HEK 293 cells that do not
express the b1-subunit. Therefore, the regulation of BK channels
by cholesterol depends on the auxiliary b1-subunit. The observa-
tion of the b1-subunit dependent regulation of BK channels by
cholesterol is supported by a recent report [38].
Several ion channels are regulated by the alterations of
membrane cholesterol [39]. Usually, increased membrane choles-
terol reduces channel activity, as seen in Kir2.x [40,41], Kir6.x
[42], voltage-gated Na+ channels [43], Ca2+ channels [44,45]. On
the other hand, several types of ion channels, such as Kir4.x [46]
are inhibited by cholesterol depletion. Cholesterol modifies kinetic
properties and current-voltage dependence of Kv1.5 and Kv2.1
channels [47]. Depletion of membrane cholesterol results in a
positive shift of the activation potential and acceleration of the
deactivation rate of hERG channels [48]. A recent study has
reported that hERG and KCNQ channels are decreased by
cholesterol enrichment via a reduced activity of phosphatidylino-
sitol 4, 5-bisphosphate (PIP2) [49].
Cholesterol regulation of BK channels is complicated. Both
down-regulation and up-regulation have been reported in various
tissue types [39]. The up-regulation of BK current by reducing
membrane cholesterol was observed in human endothelial cells
[26], myometrial smooth muscle cells [50], melanoma IGR39 cells
[20], and mouse colonic epithelial cells [25]. Nonetheless, down-
regulation of the channel by lowering cholesterol level is reported
in rat uterine myocytes [24] and human glioma cells [51]. The
present study provides the novel information that the regulation of
BK channels by cholesterol is dependent on the auxiliary b1-
subunit. In hKCa1.1-HEK 293 cells without b1-subunit expres-
sion, cholesterol enrichment resulted in no significant alteration in
current density or channel protein, while cholesterol depletion
using MbCD resulted in a reduced current but no decrease in
channel protein.
In BK-HEK 293 cells expressing both KCa1.1 and b1-subunits
and in human coronary smooth muscle cells, cholesterol enrich-
ment reduced current density and channel protein level. A
previous study reported that hypercholesterolemia decreased the
expression of b1-subunit of BK channels in cells of Oddi sphincter
from rabbits on a high cholesterol diet [52]. However, we found
that b1-subunit protein of BK channels was not affected by
cholesterol enrichment or cholesterol depletion in BK-HEK 293
Figure 5. Cholesterol regulation and channel protein degradation in BK-HEK 293 cells with co-expressing b1-subunit. A. BK channel
current recorded with the voltage protocol (inset) in cells treated with bafilomycin A1, lactacystin, MbCD-cholesterol, MbCD-cholesterol plus
bafilomycin A1, or MbCD-cholesterol plus lactacystin. B. BK channel current at +60 mV in cells treated with bafilomycin A1 (n = 16, P=NS vs. control),
lactacystin (n = 15, P=NS vs. control), MbCD-cholesterol (MbCD-chol, n = 19, **P,0.01 vs. control), MbCD-cholesterol plus bafilomycin A1 (n = 14,
##P,0.01 vs. MbCD-cholesterol), or MbCD-cholesterol plus lactacystin (n = 18, ##P,0.01 vs. MbCD-cholesterol). C. Western immunoblots showing
KCa1.1 protein in cells treated with bafilomycin A1, lactacystin, MbCD-cholesterol, MbCD-cholesterol plus bafilomycin A1, or MbCD-cholesterol plus
lactacystin. D. Mean percentage values of KCa1.1 protein in cells treated with bafilomycin A1, lactacystin, MbCD-cholesterol, MbCD-cholesterol plus
bafilomycin A1, or MbCD-cholesterol plus lactacystin (n = 6, **P,0.01 vs. control; ##P,0.01 vs. MbCD-cholesterol).
doi:10.1371/journal.pone.0079952.g005
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cells. This may suggest that the regulation of the b1-subunit by
cholesterol is likely dependent on species and/or tissue type.
It has been suggested that cholesterol may regulate ion channels
by hydrophobic mismatch between the transmembrane domains
and the lipid bilayer [53]. The ion channels are associated with
cholesterol-rich membrane domains lipid rafts (10–200 nm) which
are ‘‘heterogeneous, highly dynamic, sterol and sphingolipid
enriched domains that compartmentalize cellular processes’’
[54]. Ion channels may go through a change in conformation
within the viscous medium of the lipid membrane that may cause
deformation of the lipid bilayer surrounding the channel [39].
Kir2.x channel regulation by cholesterol is an example of the
cholesterol interaction with lipid rafts and the channel protein
[55,56].
So far, there is no confirmed model that accounts for the
diversity of cholesterol effects on BK channels. Cholesterol-
dependent modulation of the channel activity in native cellular
membranes has been found to be related to its localization to lipid
rafts [39]. The modulation of BK channels by cholesterol is
believed to be mainly due to the changes in biophysical properties
of the lipid bilayer [21]. It should be noted that the human BK
channel a-subunit KCa1.1 expressed in HEK 293 cells alone or in
combination with any of the four known b-subunits was insensitive
to acute application of cholesterol (10 mM) [57]. However,
expression of BK channels cloned from rat cerebral artery
myocytes reconstituted in binary phospholipid bilayers was
inhibited by cholesterol in a b1-subunit independent manner [58].
Cholesterol depletion or interference with caveolin scaffolding
decreased raft association with the channels, and upregulated BK
current via destabilization of lipid rafts [24,50,51]. However,
Weaver and colleagues demonstrated that cholesterol depletion
inhibited the intricate functional association of BK channels with
IP3 receptors thus resulted in a strong reduction of the channel
current [51].
The present study found that the cholesterol regulation of BK
channels was b1-subunit dependent. In hKCa1.1-HEK 293 cells
without b1-subunit expression, cholesterol depletion with MbCD
reduced the current density without reduction in KCa1.1 protein
expression. However, in BK-HEK 293 cells expressing both
KCa1.1 and auxiliary b1-subunits, cholesterol enrichment de-
creased the current density and KCa1.1 protein expression. The
decreased KCa1.1 protein expression by cholesterol enrichment
was also observed in cultured human coronary artery smooth
muscle cells. These results support the notion that the auxiliary b1-
subunit of BK channels plays a critical role in the regulation of the
channel by cholesterol.
In the present study, we found that cholesterol decreased the
open probability of BK channels, consistent with the previous
reports (see review, [59]). It has been proposed that BK channels
are regulated by cholesterol via insertion into the cell membrane
and alteration of the bilayer physical properties, thereby leading to
a direct recognition of the sterol by a protein surfacein the BK
channel [59]. The alteration of both the protein conformation and
physical properties of the lipid that surround the channel
membrane-spanning regions by cholesterol [59] likely correlates
with the present finding that the facilitation of channel protein
degradation is involved in the cholesterol enrichment-induced
reduction of BK channels, and the effect is dependent on the b1-
Figure 6. Cholesterol effect on KCa1.1 current. A. Voltage-dependent KCa1.1 current recorded in hKCa1.1-HEK 293 cells with the voltage
protocol (inset) in cells treated with cholesterol depletion (MbCD) or cholesterol enrichment (MbCD-cholesterol). B. I-V relationships of hKCa1.1
current in control (n = 19), cholesterol depletion (n = 16, *P,0.05 or **P,0.01 vs. control at 0 to +60 mV) or cholesterol-enrichment (n = 11, P=NS vs.
control). C. Percentage values of hKCa1.1 current at +60 mV in control (n = 16), cholesterol depletion (n = 19, **P,0.01 vs. control) or cholesterol
enrichment (n = 11, ##P,0.01 vs. MbCD alone). D. Single channel activity of hKCa1.1 channels recorded in cell-attached mode at +60 mV in cells
treated with 5 mM MbCD or MbCD-cholesterol. The labels C, O1 and O2 indicate the close level, 1
st and 2nd opening levels of the channel. E.
Histograms of open probability of hKCa1.1 single channels in cells treated without (control) or with cholesterol depletion (MbCD). F. Mean values of
open probability of hKCa1.1 channels in control (n = 8), MbCD (n= 6), and MbCD-cholesterol (n = 6, *P,0.05 vs. control). G. Conductance of hKCa1.1
channels in control, MbCD, and MbCD-cholesterol (n = 6–8, P=NS vs. control).
doi:10.1371/journal.pone.0079952.g006
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subunit. It is interesting to note that the b1-subunit protein is not
affected by the degradation system in cells with cholesterol
enrichment.
Collectively, the present study has demonstrated that BK
channels are down-regulated by membrane cholesterol-enrich-
ment via increasing the channel protein degradation, and the
effect is dependent on the auxiliary b1-subunit. This may provide
an explanation for the controversial results obtained from different
tissues/cells. The tissue-specific expression of the auxiliary b1-
subunit may account for the different response to cholesterol.
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